Bluejay Diagnostics (BJDX) EPS (Diluted) (2021 - 2026)
Bluejay Diagnostics (BJDX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 0.53 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.31 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 0.61 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.42 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 0.64 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 1.26 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 0.64 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 2.05 |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | -1.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.44 |
| Mar 31, 2026 | -2.05 |
| Dec 31, 2025 | -3.18 |
| Sep 30, 2025 | -4.06 |
| Jun 30, 2025 | -5.67 |
| Mar 31, 2025 | -13.79 |
| Dec 31, 2024 | -31.23 |
| Sep 30, 2024 | -307.77 |
| Jun 30, 2024 | -1,037.39 |
| Mar 31, 2024 | -1,655.75 |
| Dec 31, 2023 | -3,548.43 |
| Sep 30, 2023 | -3,405.48 |
| Jun 30, 2023 | -4,700.61 |
| Mar 31, 2023 | -4,274.94 |
| Dec 31, 2022 | -3,952.74 |
| Sep 30, 2022 | -4,619.33 |
| Jun 30, 2022 | -3,374.56 |
| Mar 31, 2022 | -3,334.67 |
| Dec 31, 2021 | -5,038.74 |
| Sep 30, 2021 | -5,145.18 |